НовостиBenzingaJefferies Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $32 Jefferies Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $32 Benzinga 2026.11.10 14:35 (GMT+0) Открыть на Benzinga Другие новости